Published in Int J Organ Transplant Med on January 01, 2014
Unlocking the Potential of Purinergic Signaling in Transplantation. Am J Transplant (2016) 0.77
Old game, new players: Linking classical theories to new trends in transplant immunology. World J Transplant (2017) 0.75
Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation. World J Hepatol (2015) 0.75
Tolerance in Kidney Transplantation: What Is on the B Side? Mediators Inflamm (2016) 0.75
Recent Progress in Cell Therapy in Solid Organ Transplantation. Int J Organ Transplant Med (2017) 0.75
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest (2003) 4.14
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med (2012) 3.27
Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant (2012) 2.46
Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science (1990) 2.25
Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant (2011) 1.78
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match. Transpl Int (2011) 1.48
Repopulation of liver endothelium by bone-marrow-derived cells. Lancet (2001) 1.39
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation (1998) 1.35
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA (2012) 1.33
Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol (2006) 1.28
Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology (1998) 1.21
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol (2004) 1.13
Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation (2011) 1.12
Cost-related immunosuppressive medication nonadherence among kidney transplant recipients. Clin J Am Soc Nephrol (2010) 1.10
Thymic transplantation for complete DiGeorge syndrome: medical and surgical considerations. J Pediatr Surg (2004) 1.06
Pediatric transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.05
Improving long-term outcomes after liver transplantation in children. Am J Transplant (2008) 0.96
The faltering solid organ donor pool in the United States (2001-2010). World J Surg (2012) 0.95
A need for biomarkers of operational tolerance in liver and kidney transplantation. Am J Transplant (2012) 0.95
Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. N Engl J Med (2000) 0.93
Induction of donor-specific tolerance to rat cardiac allografts by intrathymic inoculation of bone marrow. Surgery (1992) 0.93
The need for tolerance in pediatric organ transplantation. Pediatrics (2008) 0.92
Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol (2006) 0.91
A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation. Am J Transplant (2012) 0.88
Current status of liver transplantation. Arch Iran Med (2012) 0.86
Frontiers in nephrology: immune tolerance to allografts in humans. J Am Soc Nephrol (2007) 0.85
Monitoring the operationally tolerant liver allograft recipient. Curr Opin Organ Transplant (2010) 0.85
Immunosuppression in pediatric solid organ transplantation: opportunities, risks, and management. Pediatr Transplant (2006) 0.84
Tolerance in liver transplantation. Best Pract Res Clin Gastroenterol (2012) 0.84
Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both? Curr Opin Organ Transplant (2008) 0.83
The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplant (2004) 0.83
Long-term outcome of immunosuppression withdrawal after liver transplantation. Transplant Proc (2005) 0.82
Identification of tolerant recipients following liver transplantation. Int Immunopharmacol (2010) 0.81
[Regulatory T cell based transplant tolerance--freedom from immunosuppression]. Nihon Rinsho (2007) 0.80
Immunosuppression withdrawal after liver transplantation: what are the next steps? Transplantation (2011) 0.79
Tolerance: is it achievable in pediatric solid organ transplantation? Pediatr Clin North Am (2003) 0.79
Monitoring tolerance after human liver transplantation. Transpl Immunol (2006) 0.77
Psychiatric issues in pediatric organ transplantation. Child Adolesc Psychiatr Clin N Am (2010) 0.76
Analysis of clinical variables associated with tolerance in pediatric liver transplant recipients. Pediatr Transplant (2010) 0.76
The pits and pearls in translating operational tolerance biomarkers into clinical practice. Curr Opin Organ Transplant (2012) 0.76
Renal function following liver transplantation in children. Pediatr Transplant (2005) 0.76
The potential for tolerance in pediatric renal transplantation. Curr Opin Organ Transplant (2008) 0.76
Challenges of organ shortage for transplantation: solutions and opportunities. Int J Organ Transplant Med (2014) 0.98
Outcomes of Full-Right-Full-Left Split Liver Transplantation in Adults in the USA: A Propensity-Score Matched Analysis. Int J Organ Transplant Med (2016) 0.75
Competitive Market Analysis of Transplant Centers and Discrepancy of Wait-Listing of Recipients for Kidney Transplantation. Int J Organ Transplant Med (2015) 0.75
Mesenchymal Stem Cells and Co-stimulation Blockade Enhance Bone Marrow Engraftment and Induce Immunological Tolerance. Int J Organ Transplant Med (2015) 0.75